ULGX OTC
Urologix, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -97.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+21.9% ▲
Capital Expenditures
$42K
+46.8% ▲
5Y CAGR: -13.4%
Free Cash Flow
-$2M
+22.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-502.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | $0 | -$5M | -$4M | -$8M |
| Depreciation & Amort. | $793K | $565K | $695K | $674K | $587K |
| Stock-Based Comp. | $440K | $369K | $359K | $257K | $211K |
| Change in Working Capital | -$368K | $463K | $2M | $1M | $1M |
| Other Non-Cash Items | $47K | -$4M | $472K | -$447K | -$105K |
| Operating Cash Flow | -$1M | -$2M | -$713K | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$85K | -$272K | -$57K | -$79K | -$42K |
| Acquisitions (Net) | $0 | $0 | -$500K | -$1M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$3K | -$8K | -$32K | $0 |
| Investing Cash Flow | -$85K | -$275K | -$565K | -$1M | -$42K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $10K | $4K | $116K | $4M | $0 |
| Net Change in Cash | -$1M | -$3M | -$1M | $391K | -$2M |
| Cash End of Period | $6M | $3M | $2M | $2M | $718K |
| Free Cash Flow | -$1M | -$3M | -$770K | -$2M | -$2M |